gout medicamentation

08.02.2023 • News

Amgen-Horizon Deal under Intense Scrutiny

Amgen’s proposed acquisition of Horizon Therapeutics for $28.7 billion, including debt, would be the largest healthcare deal since AstraZeneca’s $39 billion purchase of Alexion in 2021, if it goes ahead. As such, it is under intense scrutiny.

05.01.2016 • News

US Approves AstraZeneca’s Zurampic Gout Drug

23.04.2012 • News

Astra Fuels Biotech M&A with $1.3 bln Ardea Buy

Top-Feature

Evonik Industries AG

Maximize the Potential of Spent Hydroprocessing Catalysts

Ecocool GmbH

Transport Logistic: Ecocool Presents Packaging Solutions for Pharmaceutical Transports

CAS

Pioneering End-to-End Green Chemical Production

IMCD Deutschland GmbH

Fostering Innovation and Collaboration

CHEManager Spotlight

Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.